Efficacy of Ocrelizumab in Autoimmune Encephalitis
Clinical trial NCT03835728 · TERMINATED
Trial details
- NCT number
- NCT03835728
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-22
- Primary completion
- 2020-10-02
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.